CCR2 and COVID-19: For this purpose, we identified chemokine receptor-positive cells in COVID-19 and influenza patients by boolean gating, combining cells expressing CXCR3, CXCR6, CCR2, and/or CCR5 (Figures 2, 3, See gating strategy in Figure S1B, C).